Preclinical Imaging Market Expanding At USD 3.6 Billion By 2024 : Grand View Research Inc.
San Francisco, 5 July 2019: The Report Preclinical Imaging Market Analysis By Product Type (Devices: CT, MRI, PET/SPECT, Multi-modal, Optical, Ultrasound, Photoacoustic (PAT), Reagents and Services) And Segment Forecasts To 2024 The global preclinical imaging market is expected to reach around USD 3.6 billion by the year 2024, according to a report performed by Grand View Research, Inc. The swift increase in the number of clinical research organizations (CROs), pharmaceutical companies, and research and development organizations is propelling the demand for preclinical imaging. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for Preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are the wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational instit